Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 558 is a DNA-binding transcription factor primarily found in the nucleus and is implicated in the regulation of transcription via RNA polymerase II. It is uniquely expressed in human forebrain neural progenitor cells—absent in chimpanzees—suggesting a role in human brain evolution and specifying developmental timing in neurogenesis. Mechanistically, ZNF558 evolved to repress LINE-1 transposons and has been adapted to regulate genes such as SPATA18, affecting mitochondrial homeostasis. Its expression is influenced by structural genomic variation, which may drive regulatory network changes during development
Not applicable; no drugs act on this target
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 558 (ZNF558).